INHIBITION OF MURINE CYTOCHROME P4501A BY TACRINE: IN VITRO STUDIES-Reference-Cited by-同舟云学术

INHIBITION OF MURINE CYTOCHROME P4501A BY TACRINE: IN VITRO STUDIES

Published:2004-07-16 Issue:8 Volume:32 Page:805-812
ISSN:0090-9556
Container-title:Drug Metabolism and Disposition
language:en
Short-container-title:Drug Metab Dispos

Author:

Peng Joanna Z.,Remmel Rory P.,Sawchuk Ronald J.

Publisher

American Society for Pharmacology & Experimental Therapeutics (ASPET)

Subject

Pharmaceutical Science,Pharmacology

Reference26 articles.

1. Cytochrome P450 of small intestinal epithelial cells

2. Brundage RC (1996) Investigation of the Brain Distribution and Pre-systemic Metabolism of Tacrine and Selected Metabolites using Microdialysis of Brain and Blood. Ph.D. thesis, University of Minnesota, Minneapolis, MN.

3. Cytochrome P450 specificities of alkoxyresorufin O-dealkylation in human and rat liver

4. Hydroxylation by the Hydroperoxy-Iron Species in Cytochrome P450 Enzymes

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. p-Coumaric acid attenuates the effects of Aβ42 in vitro and in a Drosophila Alzheimer’s disease model;Behavioural Brain Research;2023-08

2. CYP1A inhibitors: Recent progress, current challenges, and future perspectives;Medicinal Research Reviews;2023-06-19

3. Pharmacokinetic Drug Interaction between Tofacitinib and Voriconazole in Rats;Pharmaceutics;2021-05-18

4. Pharmacokinetic Interaction between Metformin and Verapamil in Rats: Inhibition of the OCT2-Mediated Renal Excretion of Metformin by Verapamil;Pharmaceutics;2020-05-21

5. Metabolism and Bioactivation: It’s Time to Expect the Unexpected;Journal of Medicinal Chemistry;2020-04-08